首页 > 最新文献

Journal of Nuclear Cardiology最新文献

英文 中文
Heart rate response to regadenoson stress with positron emission tomography myocardial perfusion imaging: Old marker, new insights PET MPI对再腺苷酸应激的心率反应:旧标记,新见解。
IF 2.7 4区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-12-01 DOI: 10.1016/j.nuclcard.2025.102557
Rami Doukky MD, MSc, MBA, FASNC
{"title":"Heart rate response to regadenoson stress with positron emission tomography myocardial perfusion imaging: Old marker, new insights","authors":"Rami Doukky MD, MSc, MBA, FASNC","doi":"10.1016/j.nuclcard.2025.102557","DOIUrl":"10.1016/j.nuclcard.2025.102557","url":null,"abstract":"","PeriodicalId":16476,"journal":{"name":"Journal of Nuclear Cardiology","volume":"54 ","pages":"Article 102557"},"PeriodicalIF":2.7,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145470974","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Challenging the Perugini grades: A case of 3-hour 99mTc HMDP washout 挑战Perugini等级:一个3小时99mt - hmdp冲蚀的案例
IF 2.7 4区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-12-01 DOI: 10.1016/j.nuclcard.2025.102295
Brett W. Sperry MD, Erika Hutt MD
{"title":"Challenging the Perugini grades: A case of 3-hour 99mTc HMDP washout","authors":"Brett W. Sperry MD, Erika Hutt MD","doi":"10.1016/j.nuclcard.2025.102295","DOIUrl":"10.1016/j.nuclcard.2025.102295","url":null,"abstract":"","PeriodicalId":16476,"journal":{"name":"Journal of Nuclear Cardiology","volume":"54 ","pages":"Article 102295"},"PeriodicalIF":2.7,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144575679","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The changes in myocardial perfusion imaging landscape. A look at the human factor 心肌灌注显像的改变。人的因素。
IF 2.7 4区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-12-01 DOI: 10.1016/j.nuclcard.2025.102558
Roberto Sciagrà MD
{"title":"The changes in myocardial perfusion imaging landscape. A look at the human factor","authors":"Roberto Sciagrà MD","doi":"10.1016/j.nuclcard.2025.102558","DOIUrl":"10.1016/j.nuclcard.2025.102558","url":null,"abstract":"","PeriodicalId":16476,"journal":{"name":"Journal of Nuclear Cardiology","volume":"54 ","pages":"Article 102558"},"PeriodicalIF":2.7,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145471003","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
National trends in radiopharmaceutical use for the diagnosis of cardiac amyloidosis from 2019 to 2024 2019-2024年全国心脏淀粉样变性诊断放射性药物使用趋势
IF 2.7 4区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-12-01 DOI: 10.1016/j.nuclcard.2025.102502
Mirza S. Khan MD, MS , Hima Sanjana Perumalla MD , Karnav Modi MD , Talal Asif MD , Randall C. Thompson MD , Timothy M. Bateman MD , Brett W. Sperry MD
{"title":"National trends in radiopharmaceutical use for the diagnosis of cardiac amyloidosis from 2019 to 2024","authors":"Mirza S. Khan MD, MS , Hima Sanjana Perumalla MD , Karnav Modi MD , Talal Asif MD , Randall C. Thompson MD , Timothy M. Bateman MD , Brett W. Sperry MD","doi":"10.1016/j.nuclcard.2025.102502","DOIUrl":"10.1016/j.nuclcard.2025.102502","url":null,"abstract":"","PeriodicalId":16476,"journal":{"name":"Journal of Nuclear Cardiology","volume":"54 ","pages":"Article 102502"},"PeriodicalIF":2.7,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145185640","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cardiac nuclear imaging workforce: Trends from Medicare Part B (2013–2022) 心脏核成像工作人员:医疗保险B部分趋势(2013-2022)。
IF 2.7 4区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-12-01 DOI: 10.1016/j.nuclcard.2025.102472
Maria Alwan MD , Ahmad El Yaman MD , Ahmed Sayed MD , Asim Shaikh MD , Phillips M. Lawrence MD , Mahmoud Al Rifai MD, MPH , Mouaz H. Al-Mallah MD, MSc

Background

Cardiac positron emission tomography (PET) and single-photon emission computed tomography (SPECT) are widely used for the assessment of coronary artery disease. While SPECT remains more available, workforce shortages and training demands contribute to geographic disparities in PET availability, impacting patient access to advanced imaging. Therefore, we assessed trends in the U.S. cardiac nuclear imaging workforce.

Methods

Data from Medicare Part B (2013-2022), provided by the Centers for Medicare & Medicaid Services, were analyzed to assess trends in cardiac nuclear imaging services billed by physicians. The analysis focused on the number of readers, their gender, specialty, geographic distribution, and workload.

Results

From 2013 to 2022, the proportion of SPECT procedures declined from 95.8% (2,303,194 scans; 4393 per 100,000 Medicare beneficiaries) to 86.3% (1,386,358 scans; 2130 per 100,000 Medicare beneficiaries) of total nuclear cardiology procedures, while the proportion of PET procedures increased from 4.2% (99,861 scans; 190 per 100,000 Medicare beneficiaries) to 13.7% (220,366 scans; 339 per 100,000 Medicare beneficiaries). The majority of studies were interpreted by readers performing 50 or more studies annually. From 2013 to 2022, the number of SPECT-only readers declined from 17,013 to 13,491, while PET-only readers increased from 66 to 386. Readers interpreting both SPECT and PET doubled from 822 to 1643. Only 1 in 10 nuclear imaging readers were women and the majority were cardiologists. The median (interquartile range) number of studies per reader was higher for cardiologists compared to those of other specialties. Geographic disparities were evident, with most nuclear imaging readers practicing in Texas, Florida, and California, while the fewest were in Wyoming, Alaska, Vermont, and Washington, D.C.

Conclusions

While SPECT remained the most commonly used modality in 2022, its use has declined, whereas PET use has increased, accompanied by similar trends in the number of readers. Gender and geographic disparities persist in the distribution of nuclear cardiology imaging specialists. Addressing these gaps is essential to ensuring equitable access to nuclear imaging expertise.
背景:心脏正电子发射断层扫描(PET)和单光子发射计算机断层扫描(SPECT)被广泛用于评估冠状动脉疾病。虽然SPECT仍然更容易获得,但劳动力短缺和培训需求导致PET可用性的地理差异,影响了患者获得高级成像的机会。因此,我们评估了美国心脏核成像工作人员的趋势。方法:对医疗保险和医疗补助服务中心提供的医疗保险B部分(2013-2022)数据进行分析,以评估医生计费的心脏核成像服务的趋势。分析的重点是读者的数量、性别、专业、地理分布和工作量。结果:从2013年到2022年,核心学手术中SPECT的比例从95.8%(2,303,194次扫描,4393次/ 10万医保受益人)下降到86.3%(1,386,358次扫描,2130次/ 10万医保受益人),而PET的比例从4.2%(99,861次扫描,190次/ 10万医保受益人)上升到13.7%(220,366次扫描,339次/ 10万医保受益人)。大多数研究是由每年进行50次或更多研究的读者进行解释的。从2013年到2022年,纯spect阅读器的数量从17013个下降到13491个,而纯pet阅读器的数量从66个增加到386个。同时解读SPECT和PET的读者从822人增加到1643人。只有十分之一的核成像阅读者是女性,大多数是心脏病专家。与其他专业相比,心脏病专家的每位读者的研究中位数(四分位数范围)更高。地理差异很明显,大多数核成像阅读器在德克萨斯州、佛罗里达州和加利福尼亚州使用,而怀俄明州、阿拉斯加州、佛蒙特州和华盛顿特区使用最少。结论:虽然SPECT在2022年仍然是最常用的方式,但它的使用有所下降,而PET的使用有所增加,同时伴随着阅读器数量的类似趋势。性别和地理差异仍然存在于核心学成像专家的分布中。解决这些差距对于确保公平获得核成像专业知识至关重要。
{"title":"Cardiac nuclear imaging workforce: Trends from Medicare Part B (2013–2022)","authors":"Maria Alwan MD ,&nbsp;Ahmad El Yaman MD ,&nbsp;Ahmed Sayed MD ,&nbsp;Asim Shaikh MD ,&nbsp;Phillips M. Lawrence MD ,&nbsp;Mahmoud Al Rifai MD, MPH ,&nbsp;Mouaz H. Al-Mallah MD, MSc","doi":"10.1016/j.nuclcard.2025.102472","DOIUrl":"10.1016/j.nuclcard.2025.102472","url":null,"abstract":"<div><h3>Background</h3><div>Cardiac positron emission tomography (PET) and single-photon emission computed tomography (SPECT) are widely used for the assessment of coronary artery disease. While SPECT remains more available, workforce shortages and training demands contribute to geographic disparities in PET availability, impacting patient access to advanced imaging. Therefore, we assessed trends in the U.S. cardiac nuclear imaging workforce.</div></div><div><h3>Methods</h3><div>Data from Medicare Part B (2013-2022), provided by the Centers for Medicare &amp; Medicaid Services, were analyzed to assess trends in cardiac nuclear imaging services billed by physicians. The analysis focused on the number of readers, their gender, specialty, geographic distribution, and workload.</div></div><div><h3>Results</h3><div>From 2013 to 2022, the proportion of SPECT procedures declined from 95.8% (2,303,194 scans; 4393 per 100,000 Medicare beneficiaries) to 86.3% (1,386,358 scans; 2130 per 100,000 Medicare beneficiaries) of total nuclear cardiology procedures, while the proportion of PET procedures increased from 4.2% (99,861 scans; 190 per 100,000 Medicare beneficiaries) to 13.7% (220,366 scans; 339 per 100,000 Medicare beneficiaries). The majority of studies were interpreted by readers performing 50 or more studies annually. From 2013 to 2022, the number of SPECT-only readers declined from 17,013 to 13,491, while PET-only readers increased from 66 to 386. Readers interpreting both SPECT and PET doubled from 822 to 1643. Only 1 in 10 nuclear imaging readers were women and the majority were cardiologists. The median (interquartile range) number of studies per reader was higher for cardiologists compared to those of other specialties. Geographic disparities were evident, with most nuclear imaging readers practicing in Texas, Florida, and California, while the fewest were in Wyoming, Alaska, Vermont, and Washington, D.C.</div></div><div><h3>Conclusions</h3><div>While SPECT remained the most commonly used modality in 2022, its use has declined, whereas PET use has increased, accompanied by similar trends in the number of readers. Gender and geographic disparities persist in the distribution of nuclear cardiology imaging specialists. Addressing these gaps is essential to ensuring equitable access to nuclear imaging expertise.</div></div>","PeriodicalId":16476,"journal":{"name":"Journal of Nuclear Cardiology","volume":"54 ","pages":"Article 102472"},"PeriodicalIF":2.7,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145015699","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Confirming expectations: Coronary artery calcification assessment provides diagnostic value in F18-flurpiridaz positron emission tomography myocardial perfusion imaging 证实预期-冠状动脉钙化评估在f18 -氟吡唑PET心肌灌注成像中的诊断价值
IF 2.7 4区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-12-01 DOI: 10.1016/j.nuclcard.2025.102559
Attila Feher MD, PhD , Albert J. Sinusas MD
{"title":"Confirming expectations: Coronary artery calcification assessment provides diagnostic value in F18-flurpiridaz positron emission tomography myocardial perfusion imaging","authors":"Attila Feher MD, PhD ,&nbsp;Albert J. Sinusas MD","doi":"10.1016/j.nuclcard.2025.102559","DOIUrl":"10.1016/j.nuclcard.2025.102559","url":null,"abstract":"","PeriodicalId":16476,"journal":{"name":"Journal of Nuclear Cardiology","volume":"54 ","pages":"Article 102559"},"PeriodicalIF":2.7,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145458547","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Our adventure: A year of innovation, collaboration, and global growth 我们的冒险:创新、合作和全球增长的一年
IF 2.7 4区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-12-01 DOI: 10.1016/j.nuclcard.2025.102569
Panithaya Chareonthaitawee MD, MASNC
{"title":"Our adventure: A year of innovation, collaboration, and global growth","authors":"Panithaya Chareonthaitawee MD, MASNC","doi":"10.1016/j.nuclcard.2025.102569","DOIUrl":"10.1016/j.nuclcard.2025.102569","url":null,"abstract":"","PeriodicalId":16476,"journal":{"name":"Journal of Nuclear Cardiology","volume":"54 ","pages":"Article 102569"},"PeriodicalIF":2.7,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145786714","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Incremental diagnostic value of artificial intelligence-derived coronary artery calcium in 18F-flurpiridaz positron emission tomography myocardial perfusion imaging 人工智能衍生冠状动脉钙在18f -氟吡唑PET心肌灌注显像中的增量诊断价值。
IF 2.7 4区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-12-01 DOI: 10.1016/j.nuclcard.2025.102532
Orit Barrett MD, PhD , Aakash Shanbhag MSc , Ryan Zaid BSc , Robert J.H. Miller MD , Mark Lemley BSc , Valerie Builoff BSc , Joanna X. Liang MPH , Paul B. Kavanagh MSc , Christopher Buckley PhD , Damini Dey PhD , Daniel S. Berman MD , Piotr J. Slomka PhD

Background

Positron emission tomography (PET) myocardial perfusion imaging (MPI) is a powerful tool for predicting coronary artery disease (CAD). Coronary artery calcium (CAC) provides incremental risk stratification to PET-MPI and enhances diagnostic accuracy. We assessed the additive value of the CAC score, derived from PET/CT attenuation maps to stress total perfusion deficit (TPD) results using the novel 18F-flurpiridaz tracer in detecting significant CAD.

Methods

Patients from the 18F-flurpiridaz phase III clinical trial who underwent PET/CT MPI with the 18F-flurpiridaz tracer, had available computed tomography attenuation correction (CTAC) scans for CAC scoring, and underwent invasive coronary angiography (ICA) within a 6-month period between 2011 and 2013 were included. TPD was quantified automatically, and CAC scores from CTAC scans were assessed using artificial intelligence (AI)–derived segmentation and manual scoring. Obstructive CAD was defined as ≥50% stenosis in the left main (LM) artery, or 70% or more stenosis in any of the other major epicardial vessels. Prediction performance for CAD was assessed by comparing the area under receiver operating characteristic curve (AUC) for stress TPD alone and in combination with the CAC score.

Results

Among 498 patients (72% males, median age 63 years) 30.1% had CAD. Incorporating the CAC score resulted in a greater AUC with manual scoring (AUC = .87, 95% confidence interval [CI]: .34-.90; P = .015) and AI-based scoring (AUC = .88, 95% CI: .85-.90; P = .002) compared to stress TPD alone (AUC = .84, 95% CI: .80-.92).

Conclusions

Combining automatically derived TPD and CAC score enhances 18F-flurpiridaz PET MPI accuracy in detecting significant CAD, offering a method that can be routinely used with PET/CT scanners without additional scanning or technologist time.
背景:正电子发射断层扫描(PET)心肌灌注成像(MPI)是预测冠状动脉疾病(CAD)的有力工具。冠状动脉钙(CAC)为PET-MPI提供了增量风险分层,提高了诊断准确性。我们使用新型18f -氟吡唑示踪剂评估了CAC评分的附加值,该评分来自PET/CT衰减图,以强调TPD结果,以检测显著的CAD。方法:纳入2011 - 2013年6个月期间接受18F-flurpiridaz示踪剂PET/CT MPI、可用CT衰减校正(CTAC)扫描进行CAC评分并接受有创冠状动脉造影(ICA)的18F-flurpiridaz III期临床试验患者。自动量化总灌注赤字(TPD),并使用人工智能(AI)衍生的分割和手动评分评估CTAC扫描的CAC评分。梗阻性CAD定义为左主干(LM)动脉狭窄≥50%,或其他任何主要心外膜血管狭窄≥70%。通过比较单独应力TPD和联合CAC评分的受试者工作特征曲线下面积(AUC)来评估CAD的预测性能。结果:在498例患者中(72%为男性,中位年龄63岁),30.1%患有CAD。合并CAC评分导致更大的AUC:人工评分(AUC=0.87, 95%可信区间[CI] 0.34-0.90; p=0.015)和基于ai的评分(AUC=0.88, 95%CI 0.85-0.90; p=0.002)与单独应激TPD (AUC 0.84, 95%CI 0.80-0.92)相比。结论:结合自动导出的TPD和CAC评分,可提高18F-flurpiridaz PET MPI检测显著CAD的准确性,提供了一种可与PET/CT扫描仪常规使用的方法,无需额外的扫描或技术人员时间。
{"title":"Incremental diagnostic value of artificial intelligence-derived coronary artery calcium in 18F-flurpiridaz positron emission tomography myocardial perfusion imaging","authors":"Orit Barrett MD, PhD ,&nbsp;Aakash Shanbhag MSc ,&nbsp;Ryan Zaid BSc ,&nbsp;Robert J.H. Miller MD ,&nbsp;Mark Lemley BSc ,&nbsp;Valerie Builoff BSc ,&nbsp;Joanna X. Liang MPH ,&nbsp;Paul B. Kavanagh MSc ,&nbsp;Christopher Buckley PhD ,&nbsp;Damini Dey PhD ,&nbsp;Daniel S. Berman MD ,&nbsp;Piotr J. Slomka PhD","doi":"10.1016/j.nuclcard.2025.102532","DOIUrl":"10.1016/j.nuclcard.2025.102532","url":null,"abstract":"<div><h3>Background</h3><div>Positron emission tomography (PET) myocardial perfusion imaging (MPI) is a powerful tool for predicting coronary artery disease (CAD). Coronary artery calcium (CAC) provides incremental risk stratification to PET-MPI and enhances diagnostic accuracy. We assessed the additive value of the CAC score, derived from PET/CT attenuation maps to stress total perfusion deficit (TPD) results using the novel <sup>18</sup>F-flurpiridaz tracer in detecting significant CAD.</div></div><div><h3>Methods</h3><div>Patients from the <sup>18</sup>F-flurpiridaz phase III clinical trial who underwent PET/CT MPI with the <sup>18</sup>F-flurpiridaz tracer, had available computed tomography attenuation correction (CTAC) scans for CAC scoring, and underwent invasive coronary angiography (ICA) within a 6-month period between 2011 and 2013 were included. TPD was quantified automatically, and CAC scores from CTAC scans were assessed using artificial intelligence (AI)–derived segmentation and manual scoring. Obstructive CAD was defined as ≥50% stenosis in the left main (LM) artery, or 70% or more stenosis in any of the other major epicardial vessels. Prediction performance for CAD was assessed by comparing the area under receiver operating characteristic curve (AUC) for stress TPD alone and in combination with the CAC score.</div></div><div><h3>Results</h3><div>Among 498 patients (72% males, median age 63 years) 30.1% had CAD. Incorporating the CAC score resulted in a greater AUC with manual scoring (AUC = .87, 95% confidence interval [CI]: .34-.90; <em>P</em> = .015) and AI-based scoring (AUC = .88, 95% CI: .85-.90; <em>P</em> = .002) compared to stress TPD alone (AUC = .84, 95% CI: .80-.92).</div></div><div><h3>Conclusions</h3><div>Combining automatically derived TPD and CAC score enhances <sup>18</sup>F-flurpiridaz PET MPI accuracy in detecting significant CAD, offering a method that can be routinely used with PET/CT scanners without additional scanning or technologist time.</div></div>","PeriodicalId":16476,"journal":{"name":"Journal of Nuclear Cardiology","volume":"54 ","pages":"Article 102532"},"PeriodicalIF":2.7,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145308330","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A comparative analysis of cadmium-zinc-telluride single-photon emission computed tomography/computed tomography to conventional single-photon emission computed tomography and positron emission tomography: Implications for risk stratification. CZT SPECT/CT与常规SPECT和PET的比较分析:风险分层的意义。
IF 2.7 4区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-11-29 DOI: 10.1016/j.nuclcard.2025.102583
Ahmed Ibrahim Ahmed, Ibolya Csecs, Catherine Wright, Ioannis Kyriakoulis, Damianos G Kokkinidis, Edward J Miller, Attila Feher
{"title":"A comparative analysis of cadmium-zinc-telluride single-photon emission computed tomography/computed tomography to conventional single-photon emission computed tomography and positron emission tomography: Implications for risk stratification.","authors":"Ahmed Ibrahim Ahmed, Ibolya Csecs, Catherine Wright, Ioannis Kyriakoulis, Damianos G Kokkinidis, Edward J Miller, Attila Feher","doi":"10.1016/j.nuclcard.2025.102583","DOIUrl":"10.1016/j.nuclcard.2025.102583","url":null,"abstract":"","PeriodicalId":16476,"journal":{"name":"Journal of Nuclear Cardiology","volume":" ","pages":"102583"},"PeriodicalIF":2.7,"publicationDate":"2025-11-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145654495","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Diagnostic utility of longitudinal flow gradient for diagnosis of obstructive coronary artery disease in Rubidium-82 positron emission tomography. 铷-82正电子发射断层扫描纵向流梯度诊断阻塞性CAD的应用。
IF 2.7 4区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-11-29 DOI: 10.1016/j.nuclcard.2025.102586
Yoshito Kadoya, Kevin Boczar, Anahita Tavoosi, Gary R Small, Benjamin J W Chow, Rob Beanlands, Robert deKemp

Background: The longitudinal myocardial blood flow (MBF) gradient, reflecting the basal-to-apical decline in stress MBF, has been proposed as a non-invasive marker for obstructive coronary artery disease (CAD). However, its clinical utility in Rubidium-82 (82Rb) positron emission tomography (PET) remains unestablished.

Methods: This single-center retrospective study included consecutive patients who underwent rest/dipyridamole-stress 82Rb PET myocardial perfusion imaging and invasive coronary angiography within 90 days from January 2012 to December 2019. Stress MBF and longitudinal gradients (basal-to-apical differences) were quantified in left anterior descending (LAD), left circumflex (LCX), and right coronary artery (RCA) territories. Coronary territories were stratified by coronary artery calcification (CAC) and perfusion defects (PD) into groups A (CAC-, PD-), B (CAC+, PD-), and C (PD+). Associations with CAD burden and diagnostic performance for obstructive CAD (≥50% angiographic stenosis) were evaluated using receiver operating characteristic analysis.

Results: Of 1,516 patients screened, 396 (median age: 68 years; 30.6% female) were included, contributing 1,077 coronary territories (LAD: 391; LCX: 377; RCA: 309). In LAD territory, longitudinal MBF gradients increased with CAD burden (P < 0.001) and improved diagnostic accuracy beyond relative perfusion and stress MBF (AUC 0.774 vs 0.743, P = 0.002). Conversely, gradients in LCX and RCA territories decreased with increasing CAD burden (both P < 0.001) and did not improve diagnostic performance (LCX: AUC 0.704 vs 0.715, P = 0.267; RCA: AUC 0.727 vs 0.723, P = 0.698).

Conclusions: Longitudinal stress MBF gradients derived from 82Rb PET may enhance diagnostic accuracy for obstructive CAD in the LAD territory. No additional diagnostic value was observed in LCX or RCA territories.

背景:纵向心肌血流量(MBF)梯度反映了应激MBF从基底到根尖的下降,已被提出作为阻塞性冠状动脉疾病(CAD)的无创标志物。然而,其在铷-82 (82Rb)正电子发射断层扫描(PET)中的临床应用仍未确定。方法:本研究为单中心回顾性研究,纳入2012年1月至2019年12月90天内连续接受休息/双吡啶达摩应激82Rb PET心肌灌注显像和有创冠状动脉造影的患者。对左前降(LAD)、左旋(LCX)和右冠状动脉(RCA)区域的应力MBF和纵向梯度(基底至根尖差异)进行量化。根据冠状动脉钙化(CAC)和灌注缺陷(PD)将冠状动脉区域分层分为A组(CAC-、PD-)、B组(CAC+、PD-)和C组(PD+)。使用受试者操作特征分析评估与CAD负担和阻塞性CAD(≥50%血管造影狭窄)诊断表现的关系。结果:在1516例筛查患者中,396例(中位年龄:68岁;30.6%为女性)纳入了1077个冠状动脉区(LAD: 391; LCX: 377; RCA: 309)。在LAD区域,纵向应力MBF梯度随着CAD负担的增加而增加(结论:82Rb PET获得的纵向应力MBF梯度可以提高LAD区域阻塞性CAD的诊断准确性。在LCX或RCA区域未观察到额外的诊断价值。
{"title":"Diagnostic utility of longitudinal flow gradient for diagnosis of obstructive coronary artery disease in Rubidium-82 positron emission tomography.","authors":"Yoshito Kadoya, Kevin Boczar, Anahita Tavoosi, Gary R Small, Benjamin J W Chow, Rob Beanlands, Robert deKemp","doi":"10.1016/j.nuclcard.2025.102586","DOIUrl":"10.1016/j.nuclcard.2025.102586","url":null,"abstract":"<p><strong>Background: </strong>The longitudinal myocardial blood flow (MBF) gradient, reflecting the basal-to-apical decline in stress MBF, has been proposed as a non-invasive marker for obstructive coronary artery disease (CAD). However, its clinical utility in Rubidium-82 (<sup>82</sup>Rb) positron emission tomography (PET) remains unestablished.</p><p><strong>Methods: </strong>This single-center retrospective study included consecutive patients who underwent rest/dipyridamole-stress <sup>82</sup>Rb PET myocardial perfusion imaging and invasive coronary angiography within 90 days from January 2012 to December 2019. Stress MBF and longitudinal gradients (basal-to-apical differences) were quantified in left anterior descending (LAD), left circumflex (LCX), and right coronary artery (RCA) territories. Coronary territories were stratified by coronary artery calcification (CAC) and perfusion defects (PD) into groups A (CAC-, PD-), B (CAC+, PD-), and C (PD+). Associations with CAD burden and diagnostic performance for obstructive CAD (≥50% angiographic stenosis) were evaluated using receiver operating characteristic analysis.</p><p><strong>Results: </strong>Of 1,516 patients screened, 396 (median age: 68 years; 30.6% female) were included, contributing 1,077 coronary territories (LAD: 391; LCX: 377; RCA: 309). In LAD territory, longitudinal MBF gradients increased with CAD burden (P < 0.001) and improved diagnostic accuracy beyond relative perfusion and stress MBF (AUC 0.774 vs 0.743, P = 0.002). Conversely, gradients in LCX and RCA territories decreased with increasing CAD burden (both P < 0.001) and did not improve diagnostic performance (LCX: AUC 0.704 vs 0.715, P = 0.267; RCA: AUC 0.727 vs 0.723, P = 0.698).</p><p><strong>Conclusions: </strong>Longitudinal stress MBF gradients derived from <sup>82</sup>Rb PET may enhance diagnostic accuracy for obstructive CAD in the LAD territory. No additional diagnostic value was observed in LCX or RCA territories.</p>","PeriodicalId":16476,"journal":{"name":"Journal of Nuclear Cardiology","volume":" ","pages":"102586"},"PeriodicalIF":2.7,"publicationDate":"2025-11-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145654553","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of Nuclear Cardiology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1